Outcomes following mepolizumab treatment discontinuation: real-world experience from an open-label trial
Limited information is available on the clinical course of patients with severe asthma following discontinuation of biologic treatment. Therefore, a post hoc analysis was conducted in patients with severe eosi...
Source: Allergy, Asthma and Clinical Immunology - Category: Allergy & Immunology Authors: Hector Ortega, Catherine Lemiere, Jean-Pierre Llanos, Mark Forshag, Robert Price, Frank Albers, Steven Yancey and Mario Castro Tags: Letter to the editor Source Type: research